InvestorsHub Logo
Followers 47
Posts 5233
Boards Moderated 0
Alias Born 04/03/2014

Re: Theo post# 419

Friday, 09/23/2016 12:50:18 PM

Friday, September 23, 2016 12:50:18 PM

Post# of 1347
Good to know. They're waiting for two more patients to enroll in the rhinosinusitis trial. Mostly they'll be in cohort 3 so 14 days of dosing seems like. Full data coming later this year.

Full data for phase 1 Army trial also coming later this year.

Anybody know more specific timelines here for both data releases? Looks like strong catalyst in last quarter 2016 imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARMP News